TrialBMC infectious diseases2022

HIV infection disclosure, treatment self-efficacy and quality of life in HIV-infected MSM receiving antiretroviral therapy.

Wenwen Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.